Las Vegas, NV -- (SBWIRE) -- 01/13/2014 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Ballard Power Systems Inc. (USA) (NASDAQ:BLDP), American Realty Capital Properties Inc (NASDAQ:ARCP), Dynavax Technologies Corporation (NASDAQ:DVAX), CytRx Corporation (NASDAQ:CYTR).
Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) ended its recent business day with the advanced of 18.27% and closed at the price of $2.46 after opening at $2.45. The stock traded during its last trading session with the total volume of 8.08 million shares, as compared to its average volume of 3.68 million shares. Ballard Power Systems Inc. engages in the development and commercialization of proton exchange membrane fuel cells worldwide.
Will BLDP Continue To Move Higher? Find out via this report
American Realty Capital Properties Inc (NASDAQ:ARCP) remained among the day bullish 2.52% and traded with volume of 13.53 million shares in the last session, as compared to average volume of 4.66 million shares. In comparison with 52 week range of $12.13 - $18.05, it faced lowest price of $12.68 during the last trading session whereas its day highest price was $13.03. The company’s total market capitalization is $2.41 billion, along with 185.45 million shares outstanding. American Realty Capital Properties, Inc. owns and acquires single tenant, freestanding commercial real estate that is net leased on a medium-term basis, primarily to investment grade credit rated and other creditworthy tenants.
Will ARCP Continue To Move Higher? Find out via this report
Dynavax Technologies Corporation (NASDAQ:DVAX) showed 9.67 million shares in volume during the last trading session, while the average trading volume remained 4.79 million shares. The stock kicked off its trading session at $1.94 and closed at $1.95 after rallied 0.52%. Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases.
Why Should Investors Buy DVAX After The Recent Gain? Just Go Here and Find Out
CytRx Corporation (NASDAQ:CYTR) stock traded during its last trading session with the total traded volume of 9.67 million shares versus its average volume of 4.79 million shares. The company opened its trade at the price of $1.94 and its closing price was $1.95 after gained 0.52% for the day. CytRx Corporation is a biopharmaceutical research and development company specializing in oncology.
For How Long CYTR will Fight for Profitability? Read This Trend Analysis report
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)